Brucellosis: Clinical Trials

15 trials for Brucellosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 5 not yet recruiting, 2 recruiting, 1 unknown. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Not yet recruiting 4, Completed 3

Follow Brucellosis: new trials by email Literature Review of Brucellosis trials Research Report on Brucellosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
All-Oral Fluoroquinolone-Based Triple Therapies for Adults With Imaging-Confirmed Osteoarticular Brucellosis
Doxycycline + Rifampicin + Ceftriaxone (intravenous therapy for 4 weeks), Triple oral regimen (Doxycycline + Rifampicin + Levofloxacin), Triple oral regimen (Doxycycline + Rifampicin + Moxifloxacin) - Brucellosis, Osteoarticular Brucellosis
Not applicableNot yet recruitingThe First Affiliated Hospital of Shihezi University1502026-11-012026-10-21
Fluoroquinolone-Doxycycline Oral Treatments for Adults With Uncomplicated Brucellosis
Doxycycline + Rifampicin, Doxycycline + Levofloxacin, Doxycycline + Moxifloxacin - Brucellosis
Not applicableNot yet recruitingThe First Affiliated Hospital of Shihezi University2002026-11-012026-10-21
Genotype and Phenotype in Pediatric Familial Mediterranean Fever
Familial Mediterranean Fever
Not yet recruitingAssiut University842026-09-262026-10-05
Efficacy & Safety of Fluoroquinolone-Based Brucellosis Regimens (BRUCE)
Doxycycline + Rifampicin, Doxycycline + Levofloxacin, Doxycycline + Moxifloxacin - Brucellosis, Osteoarthritis
Not applicableNot yet recruitingThe First Affiliated Hospital of Shihezi University3502026-09-012026-08-21
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Peripheral venous blood sample - Leishmaniasis, Leptospirosis
Not applicableNot yet recruitingUniversity Hospital, Montpellier1832025-03-032025-03-05
Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study
Brucella Antibody Testing (ELISA) - Brucellosis, Low Back Pain
CompletedElham Ahmed Hassan1002024-02-012025-08-08
Study of Colchicine Resistance in Familial Mediterranean Fever
Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients. - Mediterranean Fever, Colchicine Resistance
Not applicableCompletedAssistance Publique - Hôpitaux de Paris302022-12-092024-04-08
A Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With Brucellosis
Brucellosis
CompletedQin Ning2002022-04-272023-08-23
Investigation of Fever Suspected as a Zoonosis Using Advanced Diagnostic Technologies
Brucellosis, Zoonotic Disease
UnknownSoroka University Medical Center5002021-05-232021-11-01
Treadmill Stress Test With and Without Mask
Treadmill test (Bruce protocol) - Healthy
Not applicableCompletedUniversité de Sherbrooke352021-05-112021-07-27
Real World Study of Classic Infectious Disease
Antibiotics - Brucelloses, Epidemic Hemorrhagic Fever
RecruitingHuashan Hospital100002020-05-132020-05-14
Brucella Serology and History of Brucellosis in Patients With Modic Changes Type 1
Brucella serology test, Medical history for brucellosis - Brucellosis, Spinal Degeneration
CompletedVeysel Delen1182019-05-012021-06-03
Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis
MoCA - Brucellosis
CompletedMansoura University Hospital822019-02-012020-03-18
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
rk28 ICT, IT LEISH (rK39), Immunochromatographic HAT test - Visceral Leishmaniasis, Human African Trypanosomiasis
Not applicableCompletedUniversity Hospital, Geneva19272013-01-012016-10-27

Narrower conditions

Leptospirosis (3)  ·  Chikungunya Fever (2)  ·  Encephalitis, Tick-Borne (2)  ·  Familial Mediterranean Fever (2)  ·  Hepatitis E (2)  ·  Leishmaniasis (2)  ·  Leishmaniasis, Visceral (2)  ·  Malaria (2)  ·  Melioidosis (2)  ·  Q Fever (2)  ·  Rickettsia Infections (2)  ·  Zika Virus Infection (2)  ·  Zoonoses (2)  ·  Adenoviridae Infections (1)

Broader conditions

Bacterial Infections (15)  ·  Bacterial Infections and Mycoses (15)  ·  Gram-Negative Bacterial Infections (15)  ·  Infections (15)  ·  Euglenozoa Infections (4)  ·  Parasitic Diseases (4)  ·  Protozoan Infections (4)  ·  RNA Virus Infections (4)  ·  Virus Diseases (4)  ·  Digestive System Diseases (3)  ·  Liver Diseases (3)  ·  Mosquito-Borne Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Spirochaetales Infections (3)  ·  Tick-Borne Diseases (3)

Interventions

Doxycycline (3)  ·  Levofloxacin (3)  ·  Moxifloxacin (3)  ·  Rifampin (3)  ·  Ceftriaxone (2)  ·  Anti-Bacterial Agents (1)  ·  Exercise Test (1)  ·  Health Records, Personal (1)  ·  Pyrin (1)

Sponsors

The First Affiliated Hospital of Shihezi University (3)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Elham Ahmed Hassan (1)  ·  Huashan Hospital (1)  ·  Institut Pasteur du Cambodge (1)  ·  Mansoura University Hospital (1)  ·  Qin Ning (1)  ·  Soroka University Medical Center (1)  ·  University Hospital, Geneva (1)  ·  University Hospital, Montpellier (1)  ·  Université de Sherbrooke (1)  ·  Veysel Delen (1)

Countries

China (3)  ·  Cambodia (2)  ·  Egypt (2)  ·  France (2)  ·  Canada (1)  ·  Democratic Republic of the Congo (1)  ·  Israel (1)  ·  Nepal (1)  ·  Sudan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Claude Flamand, Ph.D. (1)  ·  Esmael M Ahmed, MD (1)  ·  Maher M Ahmed, prof (1)  ·  Veysel Delen (1)  ·  Warner Mampuya, MD, PhD (1)  ·  Yael Yagel, MD (1)

Results publications

PMID 15930423, PMID 16647757, PMID 27812090, PMID 35491421, PMID 38608217